Biomarker for Systemic Chronic Inflammation
The suPARbio Systemic Chronic Inflammation Test is the first in the USA that accurately measures systemic chronic inflammation, delivering actionable insights that can significantly impact health outcomes.
Easy Test Process
Blood Sample
A healthcare professional will safely collect a blood sample and securely send it to our laboratory for analysis.
Laboratory Analysis
Your sample undergoes a detailed analysis to accurately measure
the level of suPAR present
in the blood.
Get the Results
Results will be available in your profile within 7 days after analysis for you to share with your healthcare practitioner.
What Does the suPARbio Systemic Chronic Inflammation Test Measure?
The test measures the concentration of suPAR (soluble urokinase plasminogen activator receptor) in your blood, a biomarker of systemic chronic inflammation.
Indicator of Immune Activation:
Elevated suPAR levels have been associated with increased risk of cardiovascular disease, type 2 diabetes, chronic kidney disease, and other age-related conditions.
Systemic Chronic Inflammation:
Systemic chronic inflammation is a persistent, low-grade inflammatory state that is thought to play a major role in the development and progression of many chronic diseases.
Stable Biomarker:
suPAR levels have not been shown to be materially affected by short-term influences such as time of day, recent meals, common over-the-counter medications, including anti-inflammatory medications, or minor acute events like physical injuries.
Lifestyle Influences:
suPAR is a biomarker that may respond to lifestyle interventions, such as diet, exercise, stress management, and smoking cessation.
How to
Read the Results
Your results include two key values:
suPAR concentration (ng/mL)
suPARbio Age Index: A Biological Age higher than your Chronological Age may indicate accelerated biological aging, associated with elevated systemic chronic inflammation.
This test is not intended to diagnose, treat, cure, or prevent any specific disease or condition. suPAR is a non-specific marker of inflammation and may be elevated in various conditions, including serious acute infections, chronic diseases, and other inflammatory states. Results should be interpreted by a qualified healthcare provider in conjunction with clinical history, symptoms, and other laboratory findings.
Understanding Inflammaging
Inflammaging refers to the complex biological process where systemic chronic inflammation accelerates the aging process and contributes to age-related diseases.
This phenomenon links systemic chronic inflammation to various chronic diseases and is crucial for developing strategies that mitigate these risks and promote healthier aging.
How suPAR Compares to Other Biomarkers?
suPAR can provide prognostic information about disease risk that is independent of and additive to other inflammatory markers such as CRP.
Furthermore, suPAR's stability in the bloodstream makes it well-suited for tracking the effects of health interventions.
FAQs
-
The suPARbio Systemic Chronic Inflammation Test has been validated under CLIA regulations for Laboratory Developed Tests (LDTs). It has not been cleared or approved by the U.S. Food and Drug Administration (FDA).
-
Yes, the suPAR biomarker stands on 20+ years of bioscience. For a detailed look at the supporting scientific papers, please visit our Scientific Research page to learn more about how the test has been developed and validated.
-
Lower suPAR levels following lifestyle changes have been associated with a reduced risk of disease.
Stress Management
Healthy Diet
Smoking Cessation
Physical Activity
Weight Management
-
A suPARbio Age Index higher than your actual age may suggest relatively higher levels of systemic chronic inflammation, while a lower suPARbio Age Index may indicate lower levels.
This calculation is based on reference data from 9,303 healthy Danish blood donors aged 18-65 years